Firas Akhrass, MD
Endocrinology, Diabetes & Metabolism Physician · San Antonio, TX
Firas Akhrass, MD is an endocrinology, diabetes & metabolism physician with a practice address in San Antonio, Texas, and NPI 1487636205, issued on Nov 17, 2005. Check the license (Texas M3843, as entered in NPPES) on the Texas Medical Board; the Medicare figures below come from public CMS files.
- Name
- Firas Akhrass
- Credential
- MD
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License number
- M3843 TX
Self-reported in NPPES; status is on the state search - Practice location
- 5107 Medical Drive, San Antonio, TX 78229
- Phone
- (210) 614-8612
- Enumerated
- Nov 17, 2005
- Record last updated
- Jun 9, 2022
- Fax
- (210) 615-1666
- Medicaid ID
- 100454140A KS
- Medicare enrollment
- Enrolled (PECOS I20070516000321); accepts Medicare assignment
- Entity
- Type 1 · individual
Also registered at 5107 Medical Drive
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Jerome Fischer, MDEndocrinology, Diabetes & Metabolism Physician1083672679
- Stacie Haller, REGISTERED DIETITIANRegistered Dietitian1528176526
- Carla Jasso-Glavy, REGISTERED DIETITIANRegistered Dietitian1639287634
- Mark Kipnes, MDEndocrinology, Diabetes & Metabolism Physician1376501965
- Michael O'Day, RPHPharmacist1679080121
- Sherwyn SchwartzEndocrinology, Diabetes & Metabolism Physician1285692871
Verify Firas Akhrass in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersTexas Medical Board
Search for license M3843Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
4.6 times the Medicare Part D claims of the average endocrinology, diabetes & metabolism physician in 2024
12,006 Medicare Part D claims for 1,737 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 50% of claims. 23 claims were for opioids.
Most prescribed
- Levothyroxine Sodium1,006 claims
- Ozempic931 claims
- Mounjaro882 claims
- Atorvastatin Calcium607 claims
- Afrezza555 claims
- Farxiga403 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 93.3 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $134,369.24
505 payments; by number, the most common kind was food and beverage; the largest payer was Lilly USA, LLC. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Diabetes And Glandular Disease Clinic PASan Antonio, TX
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Endocrinology, Diabetes & Metabolism Physician providers in Texas
There are 743 endocrinology, diabetes & metabolism physician records in Texas.
Other endocrinology, diabetes & metabolism physician records in Texas
- Nicola Abate, MDBaytown, TX1588621692
- Randa Abdelmasih, MDGalveston, TX1003377417
- Jessica Abramowitz, MDDallas, TX1184856759
- Marconi Abreu, MDDallas, TX1144428319
- Layla Abushamat, M.D., M.P.H.Houston, TX1114306669
- Brandi Addison, D.OCorpus Christi, TX1891115275
- Reshmi Adupa, MDOdessa, TX1265008882
- Azhar Afaq, M.D.Fort Worth, TX1518906569
- Priyanka AgarwalIrving, TX1326466145
- Kelly Aguilar, M.D.Spring, TX1932316395
Common questions
What is Firas Akhrass, MD's NPI number?
Firas Akhrass, MD's National Provider Identifier (NPI) is 1487636205, issued on Nov 17, 2005. An NPI identifies a provider in billing; it is not a license.
Where is Firas Akhrass, MD located?
The NPPES record lists a practice address at 5107 Medical Drive, San Antonio, TX, 78229. Phone: (210) 614-8612. Providers update this record themselves, so call before visiting.
How can I verify Firas Akhrass, MD's license?
NPPES lists Texas license number M3843, as entered by the provider. Search the Texas Medical Board at https://profile.tmb.state.tx.us/Search.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Firas Akhrass, MD prescribe under Medicare Part D?
In 2024, Firas Akhrass, MD had 12,006 Medicare Part D claims for 1,737 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
What is Firas Akhrass, MD's MIPS final score?
The 2023 MIPS final score is 93.3 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.